Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyDisease description

Pathophysiology

12 evidence topics · 13 sources

Threat-response circuitry: anxiety disorders

“This research suggests that perturbed threat responding in anxiety disorders involves dysfunction in the circuitry that supports core psychological processes, such as attention, emotion, learning, and memory.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Many brain imaging studies have examined the structure of regions that basic neuroscience implicates in threat responding, showing structural alterations in anxiety disorders within medial temporal, prefrontal cortex, and cingulate regions.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“With functional MRI, patients who are anxious have an altered response in temporal and prefrontal brain regions, which has also been shown in functional MRI research regarding attention.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“When people are exposed to stressors, such as public speaking, scary pictures, or painful stimulation, studies generally report increased stress responses in people with anxiety disorders versus controls across many measures.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“For peripheral measures, rarely do effect sizes exceed a Cohen’s d of 0·50, indicating that these are not useful biomarkers that currently guide diagnosis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote